Mini Review - Pharmaceutical Bioprocessing (2023) Volume 11, Issue 4
Optimizing Bioprocessing Techniques for Pharmaceutical Manufacturing
Department of Pathology, University of Sydney, Australia
Department of Pathology, University of Sydney, Australia
Received: 30-Jun-2023, Manuscript No. FMBP-23-108031; Editor assigned: 03-Jul-2023, PreQC No. FMBP-23-108031 (PQ); Reviewed: 17-Jul-2023, QC No FMBP-23- 108031; Revised: 21-Jul-2023, Manuscript No. FMBP-23-108031 (R); Published: 28-Jul-2023, DOI: 10.37532/2048-9145.2023.11(4).71-73
Pharmaceutical bioprocessing refers to the use of biological systems, such as cells, microorganisms, or enzymes, to produce pharmaceutical products, including therapeutic drugs, vaccines, and biologics. This process involves various stages of development, optimization, and production to ensure the efficient and cost-effective manufacturing of pharmaceutical products using living organisms. The process begins with the identification and selection of suitable cell lines or microorganisms that can express the desired pharmaceutical product efficiently. Upstream Processing: This stage involves the cultivation and growth of the selected cell lines or microorganisms in bioreactors under controlled conditions. The cells are provided with appropriate nutrients, temperature, pH, and oxygen supply to promote optimal growth and productivity.
Bioprocessing techniques• Pharmaceutical manufacturing• Optimization• Upstream processing
In this step, large-scale production of the pharmaceutical product occurs through fermentation (for microorganisms) or cell culture (for mammalian cells). The cells or microorganisms are allowed to express and secrete the desired pharmaceutical product. Harvesting and Recovery: After the desired product has been produced by the cells or microorganisms, the bioprocess involves separating the product from the culture medium. This step may include cell separation, filtration, centrifugation, or chromatography.
During downstream processing, the product is further purified and concentrated to remove impurities, by-products, and other contaminants. This stage often involves multiple purification steps, such as chromatography, filtration, and ultrafiltration. Formulation and Fill-Finish: Once the product has been purified, it is formulated into its final dosage form. This step may involve adding stabilizers, preservatives, and other excipients to ensure the product’s stability and efficacy. The final product is then filled into vials, syringes, or other containers for distribution. Quality Control and Testing: Throughout the entire bioprocessing workflow, strict quality control measures are applied to ensure the safety, purity, and potency of the pharmaceutical product. Analytical techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry, are used to verify product identity and quality [1-5].
Pharmaceutical bioprocessing is a critical aspect of modern medicine, as it allows for the production of complex and sensitive biological products that cannot be synthesized through traditional chemical processes. This technology has played a significant role in the development of many life-saving drugs and vaccines. However, bioprocessing can be a challenging and expensive process due to the intricacies of working with living organisms, the need for highly controlled environments, and the strict regulatory requirements in the pharmaceutical industry. Pharmaceutical bioprocessing is a crucial aspect of the pharmaceutical industry that involves the use of biological systems, such as living cells or organisms, to produce therapeutic drugs or other pharmaceutical products. It is a specialized field that focuses on the development, production, and purification of biologically derived pharmaceuticals, including biologics, vaccines, gene therapies, and more.
The process starts with selecting a suitable cell line or microorganism that can efficiently produce the desired pharmaceutical product. This cell line is often genetically engineered to enhance productivity and optimize the production process. Upstream Processing: This phase involves the cultivation of the selected cell line in bioreactors or fermentation vessels. The cells are provided with the necessary nutrients, and environmental conditions are carefully controlled to promote growth and the production of the desired pharmaceutical compound. Bioreactor Operation: Bioreactors are vessels used for large-scale cultivation of cells. They provide an environment with controlled temperature, pH, oxygen levels, and agitation to support cell growth and maximize product yield [6-10].
Once the cells have produced the pharmaceutical product, the culture broth is harvested. This can be a complex mixture containing the desired compound along with other cellular components. Downstream Processing: This step involves purifying the desired pharmaceutical product from the harvested culture broth. Various separation and purification techniques, such as chromatography, filtration, centrifugation, and precipitation, are employed to isolate the target compound from impurities. Formulation and Fill-Finish: After purification, the pharmaceutical product may undergo formulation, where it is prepared in a specific dosage form suitable for administration (e.g., liquid, lyophilized powder). Then, the final product is filled into vials, syringes, or other containers for distribution and use.
Throughout the entire bioprocessing workflow, quality control measures are essential to ensure the safety, efficacy, and consistency of the pharmaceutical product. Rigorous testing and analysis are performed at various stages to meet regulatory standards and guidelines. Biopharmaceuticals have revolutionized modern medicine, providing treatments for various diseases, including cancer, autoimmune disorders, and genetic diseases. However, the bioprocessing of pharmaceuticals can be complex and requires expertise in biology, engineering, and pharmaceutical sciences to ensure efficient production and high-quality products. As technology advances, pharmaceutical bioprocessing continues to evolve, leading to more sophisticated techniques and the development of innovative therapeutics.
Pharmaceutical bioprocessing refers to the use of biological systems, such as living cells or microorganisms, to produce pharmaceutical products on a large scale. This field combines principles of biology, biotechnology, engineering, and chemistry to develop and optimize processes for manufacturing drugs and therapeutic proteins. The first step is to select or engineer a suitable cell line that can produce the desired pharmaceutical product. This could be a mammalian cell line, microbial cell, or yeast, depending on the nature of the product. In this stage, the selected cell line is grown in large bioreactors under controlled conditions. For microbial products, it involves fermentation, while for mammalian cell-produced products, it is referred to as cell culture.Once the cells have produced the target product, they need to be separated from the culture medium. Various techniques like centrifugation, filtration, and chromatography are used to isolate and recover the pharmaceutical product.
Pharmaceutical bioprocessing refers to the use of biological systems, such as living cells or microorganisms, to produce pharmaceutical products on a large scale after harvesting the product might still contain impurities, so purification steps are employed to obtain a highly pure pharmaceutical substance. Chromatography, ultrafiltration, and other techniques are used to achieve this. The purified pharmaceutical product is then formulated into its final dosage form. This could be tablets, capsules, injections, or other forms suitable for administration. Quality Control and Analysis: Throughout the entire bioprocessing workflow, quality control measures are implemented to ensure that the product meets specific standards and is safe for use. Analytical techniques are used to assess the product’s identity, purity, potency, and safety. Pharmaceutical bioprocessing is a critical aspect of the biopharmaceutical industry, where it plays a crucial role in producing therapeutic proteins, vaccines, and other biologic medicines. It involves complex and precise procedures to ensure the consistency and safety of pharmaceutical products on a commercial scale.
- Sketris, IS. American Geriatrics Society Beers Criteria®Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria®for Potentially Inappropriate Medication Use in Older Adults.J Am Geriatr Soc.67, 674–694 (2019).
- Gore R, Chugh PK, Tripathi CD. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.Curr Clin Pharmacol.12, 18–25 (2018).
- Barry E, Moriarty F, Boland F et al. The PIPc Study-application of indicators of potentially inappropriate prescribing in children (PIPc) to a national prescribing database in Ireland: A cross-sectional prevalence study.BMJ Open.8, 69-556 (2019).
- Tommelein E, Mehuys E, Petrovic M et al. Potentially inappropriate prescribing in community-dwelling older people across Europe: A systematic literature review.Eur J Clin Pharmacol.71, 1415–1427.
- Hill-Taylor B, Walsh KA, Stewart S et al. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: Systematic review and meta-analysis of randomized controlled studies.J Clin Pharm Ther.41, 158–169 (2016).
- Prot-Labarthe S, Weil T, Angoulvant F et al. POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): Development of a tool to identify inappropriate prescribing.PLoS ONE.9,25-68.
- Aagaard L. Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects. Clin Pharmacol Toxicol.117, 215–218(2015).
- Van den Anker J, Reed MD, Allegaert K et al. Developmental Changes in Pharmacokinetics and Pharmacodynamics.J Clin Pharmacol.58, 10-25 (2018).
- Corrick F, Conroy S, Sammons H et al. Paediatric Rational Prescribing: A Systematic Review of Assessment Tools.Int J Environ Res Public Health.17, 1473-1496 (2015).
- Sadozai L, Sable S, Le E Roux et al. International consensus validation of the POPI tool (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions) to identify inappropriate prescribing in pediatrics.PLoS ONE.15, 47-72 (2018).